We are committed to better health in Indonesia through new healthcare and product offers using the diverse talent and passion within Takeda.

Since our establishment in Indonesia in 1971 Takeda has come far. We are headquartered in Tokyo, Japan and part of a global network of pharmaceutical markets with representation in over 70 countries. In Indonesia, Takeda produces both ethical and over the counter (OTC) products. We are in the process of migrating from two to one enlarged production site at Bekasi and over the last 12 months have launched two new products as part of our commitment to the Indonesian market.

Core therapeutic areas of expertise include Cardiovascular & Metabolic, Oncology, Gastrointestinal plus Established Products that include Antibiotics, Anti-inflammatories and Central Nervous System medicines.

In line with our global strategy, we aim to create and sustain value for all local stakeholders. This we can achieve by combining the benefits of our global expertise through existing products and the launch of new medicines to contribute to better health alongside activities to support corporate social responsibility and the needs of local society.